Relacorilant
Auto-discovered · not yet curatedrelacorilant
Educational only, not medical advice. OncoForge makes no claim that Relacorilant treats, prevents, or cures any condition, beyond what the linked studies show. Evidence levels vary; effects may not translate to people, and some compounds can cause harm. Always coordinate with your oncology team.
Simple Summary
Auto-discovered from 1 recent study; not yet curated.
Research
No published studies for Relacorilant yet
New studies appear here once they’ve been reviewed. Browse all studies.
Trials studying Relacorilant
3 recruiting on ClinicalTrials.gov. Recruiting is not the same as proven. Search ClinicalTrials.gov →
- Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological CancersNCT06906341Phase 2Recruiting
- Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic AdenocarcinomaNCT07259317Phase 2Recruiting
- A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate CancerNCT05726292Phase 2Recruiting
Inclusion here is not an endorsement. OncoForge makes no claim beyond what the linked studies show. Discuss anything on this page with your oncology team before acting on it.